Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Vrtala

Showing results (31-40 of 78) with videos related to

Pageof 8
Sort By:
Biochemical and Biophysical Research Communications|September 4, 1996
High-level expression in Escherichia coli and purification of recombinant plant profilins: comparison of IgE-binding capacity and allergenic activityS Vrtala, P Wiedemann, I Mittermann, et al.
International Archives of Allergy and Immunology|May 4, 1999
The importance of recombinant allergens for diagnosis and therapy of IgE-mediated allergiesD Kraft, F Ferreira, S Vrtala, et al.
The Journal of Allergy and Clinical Immunology|July 11, 2000
Comparison of inflammatory responses to genetically engineered hypoallergenic derivatives of the major birch pollen allergen bet v 1 and to recombinant bet v 1 wild type in skin chamber fluids collected from birch pollen-allergic patientsA Nopp, G Halldén, J Lundahl, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|March 16, 2012
Molecular characterization of wheat allergens specifically recognized by patients suffering from wheat-induced respiratory allergyS Pahr, C Constantin, A Mari, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|January 6, 2006
Absence of systemic immunologic changes during dose build-up phase and early maintenance period in effective specific sublingual immunotherapy in childrenE Dehlink, T Eiwegger, M Gerstmayr, et al.
Wiener Klinische Wochenschrift|January 1, 1993
[New concepts in therapy of type I allergic diseases]R Valenta, P Steinberger, S Vrtala, et al.
Biological Chemistry|September 24, 1999
Genetically engineered and synthetic allergen derivatives: candidates for vaccination against type I allergyR Valenta, S Vrtala, M Focke-Tejkl, et al.
Gene|October 16, 1999
pET-prof, a plasmid for high-level expression of recombinant peptides fused to a birch profilin-derived hexadecapeptide tag: a system for the detection and presentation of recombinant antigensB Pandjaitan, P B Eibensteiner, S Vrtala, et al.
The Journal of Allergy and Clinical Immunology|December 1, 1991
Recombinant allergens for immunoblot diagnosis of tree-pollen allergyR Valenta, M Duchene, S Vrtala, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|October 10, 2002
Nasal challenges with recombinant derivatives of the major birch pollen allergen Bet v 1 induce fewer symptoms and lower mediator release than rBet v 1 wild-type in patients with allergic rhinitisM van Hage-Hamsten, E Johansson, A Roquet, et al.
Pageof 8

Showing results (31-40 of 78) with videos related to

Sort By:
Pageof 8
Biochemical and Biophysical Research Communications|September 4, 1996
High-level expression in Escherichia coli and purification of recombinant plant profilins: comparison of IgE-binding capacity and allergenic activityS Vrtala, P Wiedemann, I Mittermann, et al.
International Archives of Allergy and Immunology|May 4, 1999
The importance of recombinant allergens for diagnosis and therapy of IgE-mediated allergiesD Kraft, F Ferreira, S Vrtala, et al.
The Journal of Allergy and Clinical Immunology|July 11, 2000
Comparison of inflammatory responses to genetically engineered hypoallergenic derivatives of the major birch pollen allergen bet v 1 and to recombinant bet v 1 wild type in skin chamber fluids collected from birch pollen-allergic patientsA Nopp, G Halldén, J Lundahl, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|March 16, 2012
Molecular characterization of wheat allergens specifically recognized by patients suffering from wheat-induced respiratory allergyS Pahr, C Constantin, A Mari, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|January 6, 2006
Absence of systemic immunologic changes during dose build-up phase and early maintenance period in effective specific sublingual immunotherapy in childrenE Dehlink, T Eiwegger, M Gerstmayr, et al.
Wiener Klinische Wochenschrift|January 1, 1993
[New concepts in therapy of type I allergic diseases]R Valenta, P Steinberger, S Vrtala, et al.
Biological Chemistry|September 24, 1999
Genetically engineered and synthetic allergen derivatives: candidates for vaccination against type I allergyR Valenta, S Vrtala, M Focke-Tejkl, et al.
Gene|October 16, 1999
pET-prof, a plasmid for high-level expression of recombinant peptides fused to a birch profilin-derived hexadecapeptide tag: a system for the detection and presentation of recombinant antigensB Pandjaitan, P B Eibensteiner, S Vrtala, et al.
The Journal of Allergy and Clinical Immunology|December 1, 1991
Recombinant allergens for immunoblot diagnosis of tree-pollen allergyR Valenta, M Duchene, S Vrtala, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|October 10, 2002
Nasal challenges with recombinant derivatives of the major birch pollen allergen Bet v 1 induce fewer symptoms and lower mediator release than rBet v 1 wild-type in patients with allergic rhinitisM van Hage-Hamsten, E Johansson, A Roquet, et al.
Pageof 8